Allogene Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Allogene Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2024.
  • Allogene Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $3.1M, a 3.33% increase year-over-year.
  • Allogene Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $12M, a 26.3% increase from 2022.
  • Allogene Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $9.5M, a 58.3% increase from 2021.
  • Allogene Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $6M, a 3.23% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.1M +$100K +3.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $3M +$1M +50% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q1 2022 $2M +$1M +100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-04
Q1 2021 $1M -$400K -28.6% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-05
Q1 2020 $1.4M Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.